Medtronic (MDT) Debt to Equity (2014 - 2026)

Medtronic has disclosed Debt to Equity across 13 years of filings, most recently posting $0.57 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.57, up 6.4% year-over-year; the trailing twelve-month figure through Jan 2026 was $0.57 (up 6.4% YoY), and the FY2025 annual result was $0.59, up 19.06% from the prior year.
• Debt to Equity came in at $0.57 for Q1 2026 at Medtronic, down from $0.6 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.6 in Q4 2025 to a low of $0.44 in Q3 2022.
• The 5-year median for Debt to Equity is $0.51 (2022), against an average of $0.52.
• Across the five-year window, Debt to Equity retreated 19.85% in 2022 and rose 19.74% in 2024, its largest moves.
• Medtronic's Debt to Equity stood at $0.51 in 2022, then fell by 5.03% to $0.49 in 2023, then advanced by 19.74% to $0.58 in 2024, then gained by 2.44% to $0.6 in 2025, then fell by 4.2% to $0.57 in 2026.
• The last three Debt to Equity figures came in at $0.57 (Q1 2026), $0.6 (Q4 2025), and $0.59 (Q3 2025), per Business Quant data.